Veterinary Medicine Information website

Nobilis CAV P4

Authorised
  • Chicken anaemia virus, strain 26P4, Live
Download as PDF

Product identification

Medicine name:
Nobilis CAV P4
Active substance:
  • Chicken anaemia virus, strain 26P4, Live
Target species:
  • Chicken
Route of administration:
  • Wing-web-stab use
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Chicken anaemia virus, strain 26P4, Live
    3.00
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Withdrawal period by route of administration:
  • Wing-web-stab use
    • Chicken
      • Meat and offal
        no withdrawal period
      • Egg
        no withdrawal period
  • Intramuscular use
    • Chicken
      • Meat and offal
        no withdrawal period
      • Egg
        no withdrawal period
  • Subcutaneous use
    • Chicken
      • Meat and offal
        no withdrawal period
      • Egg
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:
  • Cardboard box with 10 x 200 ml solvent Dilavia: 250 ml glass (type II) or PET vial with halogenobutyl rubber stopper and coded aluminium capsule
  • Cardboard box with 10 x 13 ml solvent Unisolve: 20 ml glass vial (type II) with halogenobutyl rubber stopper and coded aluminium capsule.
  • Cardboard box with 10 x 1000 doses of vaccine - Lyophilisate: 10 ml glass vial (type I) with halogenobutyl rubber stopper and coded aluminium capsule
  • Cardboard box with 1 x 200 ml solvent Dilavia: 250 ml glass (type II) or PET vial with halogenobutyl rubber stopper and coded aluminium capsule
  • Cardboard box with 1 x 13 ml solvent Unisolve: 20 ml glass vial (type II) with halogenobutyl rubber stopper and coded aluminium capsule
  • Cardboard box with 1 x 1000 doses Lyophilisate: 10 ml glass vial (type I) with halogenobutyl rubber stopper and coded aluminium capsule

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 18039
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/8659/001
Concerned member states:
  • Belgium
  • Denmark
  • Finland
  • Germany
  • Portugal

Documents

Summary of Product Characteristics

English (PDF)
Published on: 26/08/2024
Download
Danish (, LYOFILISAT OG SOLVENS TIL INJEKTIONSVÆSKE, SUSPENSION)
Published on: 11/11/2024
Download